2 completed, 1 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1 |
Follow Neuromuscular Blocking Agents: new trials by email Literature Review of Neuromuscular Blocking Agents trials Research Report on Neuromuscular Blocking Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia pipecuronium bromide, Rocuronium bromide - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Not yet recruiting | Tamas Vegh, MD | 80 | 2025-06-26 | 2025-06-29 |
| Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia pipecuronium bromide, Rocuronium bromide - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Active not recruiting | Tamas Vegh, MD | 80 | 2025-06-26 | 2025-08-07 |
| Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis Sevofluorane, Propofol - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Enrolling by invitation | Tamas Vegh, MD | 20 | 2024-07-06 | 2025-08-05 |
| Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Neostigmine, Sugammadex - Urinary Retention Postoperative, Laparoscopic Cholecystectomy | Phase 4 | Completed | University of Texas Southwestern Medical Center | 235 | 2023-09-11 | 2024-10-09 |
| Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium Reversal of moderate neuromuscular blockade, Reversal of superficial neuromuscular blockade, Two-step reversal - Neostigmine, Neuromuscular Blocking Agents | Phase 4 | Completed | Pontificia Universidade Catolica de Sao Paulo | 60 | 2021-06-01 | 2022-05-19 |
Delayed Emergence from Anesthesia (3) · Muscle Weakness (1)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Postoperative Complications (3) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Signs and Symptoms (1)
Pipecuronium (2) · Rocuronium (2) · Neostigmine (1) · Propofol (1) · Sugammadex (1)
Tamas Vegh, MD (3) · Pontificia Universidade Catolica de Sao Paulo (1) · University of Texas Southwestern Medical Center (1)
Hungary (3) · Brazil (1) · United States (1)
Eduardo T Moro, MD (1) · Tiffany Moon, MD (1)